NCT04001374View on ClinicalTrials.gov

Platelet Sub-study of the TWILIGHT Trial

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 28, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Coronary Artery DiseaseMyocardial Infarction
Interventions
DRUG

Ticagrelor

90mg tablet bid for 12 months

DRUG

ASA

enteric coated aspirin 81mg-100mg daily p.o. for 12 months

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Juan Badimon

OTHER

NCT04001374 - Platelet Sub-study of the TWILIGHT Trial | Biotech Hunter | Biotech Hunter